Adam Brufsky, MD, PhD, and Sreejata Raychaudhuri, MD, recently discussed how the novel HER2+ therapies fit into breast cancer treatment.
Adam Brufsky, MD, PhD, and Sreejata Raychaudhuri, MD, recently discussed how the novel HER2+ therapies fit into breast cancer treatment.
Adam Brufsky, MD, PhD, and...